MONTREAL, July 23, 2018 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, is pleased to announce the signing of an exclusive agreement with Medicals International for distribution rights in the Middle East for its patented I-PEN® Tear Osmolarity System.
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/21e18d01-abd6-439e-af3f-f97cbbfefd37
The I-PEN® Osmolarity System is the world’s first, handheld platform that offers eye care professionals a quick and reliable tool for screening dry eye patients.
Daniel Hofmann, President of I-MED Pharma said, “Medicals International is a promising partner for us with established market expertise and a unique vision for expanding access of our cutting-edge products to both eye care professionals and dry eye patients in the Middle East. We are excited by the opportunity present in this region and will be working closely with Medicals International to launch our I-PEN® Tear Osmolarity System in the upcoming months.”
Walid Barake, President and Founder of Medicals International, commented, “It is our great pleasure to be going into partnership with I-MED Pharma Inc. to bring to the market a tool for screening an eye condition of such ubiquitous nature in this region – dry eyes. We are excited about the opportunities this product holds. We trust that this will bring us mutual success, all the while granting a great deal of ease of mind to practitioners and ultimately patients in the MENA and Cyprus.”
I-MED Pharma Inc. is a privately held Canadian company, headquartered in Montreal, Quebec, servicing Canadian ophthalmologists, optometrists and the global eye care community. Established almost thirty years ago, I-MED Pharma creates and distributes innovative medical, surgical and veterinary eye care products worldwide. It continually researches, develops and sources the most effective and advanced solutions to eye disorders like cataracts, corneal degeneration, dry eye, glaucoma and Meibomian gland disease.
I-MED Pharma is proud to have been at the forefront of treating Dry Eye Syndrome as a serious disease and invests heavily into education and developing effective dry eye products. I-MED Pharma’s ocular surface disease product range includes diagnostic tools, ocular hygiene, nutrition, dry eye drops, and therapeutic accessories.
About Medicals International
Established in 1994, Medicals International is a distributor of specialized medical and optical supplies to the MENA region and Cyprus, with 17 offices operating regionally. Medicals International is headquartered in Lebanon and caters to a wide range of clients, including the region’s top tier medical institutions and establishments. With a vast product portfolio of specialized international brands and over 20 years of solid experience in the industry, Medicals International has established itself as one of the leading medical distribution firms in the region.
For more information, please email media@imedpharma.com or visit imedpharma.com.